Did you know approximately 70% of cancer patients don’t respond to their first course of chemotherapy? Accurately determining whether or not your patients are responding is critical, as enduring treatment is one of the toughest challenges they’ll ever face. One form of response measurement is SUV, standardized uptake value. What if we could offer a way of measuring response to treatment, via SUV, with PET reconstruction technology you can trust, helping to provide an earlier view of how well a treatment is working? With Q.Clear, we think it’s possible.
For the first time in PET reconstruction, no trade-off between excellent image quality and quantitative SUV accuracy. Q.Clear, full convergence reconstruction, delivers fast and efficient reading for confident diagnosis and precise treatment response assessment. It provides up to 2 times improvement in both PET quantitation accuracy (SUVmean) and image quality (SNR).
A critical element in improving the value of PET for everyone – from reading physicians to referring physicians to patients – is the report produced by radiologists. The report needs to contain, hold and communicate more value. Its language and contents must continually improve so that reading physicians perceive PET as more conclusive and less subjective. Improving the communication among physicians on care teams comes down to improving the language of the PET report. We believe that Q.Clear and the Q.SUV measurement it produces will play a major role in improving these reports as quantitation is the communication language between reading physicians and referring physicians. So, improving quantitation improves communication.